Encorafenib (Braftovi,Bratodx)

Encorafenib is an oral, highly selective BRAF V600 mutant kinase inhibitor, often used in combination with MEK inhibitors for enhanced efficacy.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Encorafenib Medication Q&A

Is there a risk of bleeding during treatment?

Risk of hemorrhage. Advise patients to promptly contact a healthcare professional and seek urgent medical care if they experience any signs or symptom···【More】
Update: 19 Mar,2026Source: BigbearViews: 90
Is there a risk of new primary malignancies during treatment?

Risk of new primary malignancies. Instruct patients to contact their healthcare provider immediately if they develop new skin lesions, changes in pre-···【More】
Update: 19 Mar,2026Source: BigbearViews: 96
What to do if a dose is missed?

If a dose of encorafenib is missed by more than 12 hours or if vomiting occurs after administration, the next dose should be taken at the next regular···【More】
Update: 19 Mar,2026Source: BigbearViews: 88